Recurrent glomerulonephritis in renal transplants: fourteen years' experience

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Y O'MearaJ Walshe

Abstract

A retrospective study of the clinical records and biopsy specimens of all transplants performed between 1974 and 1987 was carried out. Recurrent glomerulonephritis was diagnosed only in those patients who had precise histological classification of their original disease. Of a total of 737 transplants performed in 633 recipients. 603 were from cadaveric and 134 from living related donors. Of 295 patients who were clinically classed as having chronic glomerulonephritis, histological confirmation was available in 156 (54%) as follows: membranoproliferative glomerulonephritis 34%, diffuse proliferative glomerulonephritis 27%, crescentic glomerulonephritis 13% IgA neuropathy 10%, focal sclerosing glomerulonephritis 10%, and membranous nephropathy 7%. There were 24 cases of recurrence in 23 recipients. Of these, 16 occurred in living-related and 8 in cadaveric grafts. Membranoproliferative glomerulonephritis recurred in 14 (8 type I and 6 type II), focal sclerosing glomerulonephritis in 5, IgA neuropathy in 3, crescentic glomerulonephritis in 1 and membranous nephropathy in 1. Graft failure occurred in 13 patients (54%) and was directly attributable to recurrent disease in 12. Membranoproliferative glomerulonephritis caused 8 graft l...Continue Reading

Citations

Sep 15, 1999·Clinical Transplantation·P FreeseG Nyberg
Jun 2, 2000·Seminars in Dialysis·S Hariharan
Oct 1, 2013·Clinical Transplantation·Hyo Jin KimJung Pyo Lee
Apr 24, 2014·Clinical Transplantation·Gabriella MoroniPiergiorgio Messa
Apr 27, 1997·Transplantation·P KotankoJ B Levy
May 31, 2001·Irish Journal of Medical Science·A StackJ Donohoe
Dec 1, 1995·Scandinavian Journal of Urology and Nephrology·G NybergG Nordén
Feb 6, 2009·Journal of the American Society of Nephrology : JASN·Worawon ChailimpamontreeUNKNOWN Genome Canada Biomarkers in Transplantation Group
Jul 1, 1991·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J S Cameron
Jul 22, 2004·Pediatric Transplantation·Claudio PonticelliGiovanni Banfi
Mar 3, 2012·Transplant International : Official Journal of the European Society for Organ Transplantation·Anuja JavaDaniel C Brennan
Jan 1, 1995·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·M R First
Dec 3, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Leila BenabdallahHenri Kreis
Feb 29, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Y H Lien, K Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Ali J Hashim Al-Saedi
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
S Hisano, K Ueda
© 2022 Meta ULC. All rights reserved